LOGO
LOGO

Article Search

Discover the power of RTTNews website's advanced search page, designed for seamless Article retrieval by Company Name, Stock Symbol, and other criteria.
Stay updated with the Latest News on specific Companies, Financial Insights, and Market Trends. We Ensure you to get the most relevant information instantly.

Symbol  
Company  
Currency Symbol   eg (EUR/USD)
Keyword  
  • Wedbush Reiterates NovoCure (NVCR) At Outperform With $29 Up From $25 Price Target 10/27/2017 10:46:19 AM
  • Wedbush Is Lowering NovoCure (NVCR) FY18 Rev. Estimate To 235.6 M From 250.2 M 10/27/2017 10:45:40 AM
  • Wedbush Is Increasing NovoCure (NVCR) FY17 Rev. Estimate To 182.7 M From 162.8 M 10/27/2017 10:43:48 AM
  • Wedbush Is Increasing NovoCure (NVCR) Q4 17 Rev. Estimate To 51.3 M From 47.2 M 10/27/2017 10:43:20 AM
  • Wedbush Is Lowering NovoCure (NVCR) FY18 Estimate To -0.68 From -0.46 10/27/2017 10:39:24 AM
  • Wedbush Is Raising NovoCure (NVCR) FY17 Estimate To -0.62 From -0.85 10/27/2017 10:39:02 AM
  • Wedbush Is Raising NovoCure (NVCR) Q4 17 Estimate To -0.14 From -0.19 10/27/2017 10:38:40 AM
  • Wedbush Is Cutting NovoCure (NVCR) 2018 Estimate To -0.46 From -0.43 7/28/2017 11:22:17 AM
  • Wedbush Is Raising NovoCure (NVCR) 2017 Estimate To -0.85 From -0.96 7/28/2017 11:21:55 AM
  • Wedbush Is Raising NovoCure (NVCR) 4Q17 Estimate To -0.19 From -0.25 7/28/2017 11:21:35 AM
  • Wedbush Is Increasing NovoCure (NVCR) 3Q17 Estimate To -0.21 From -0.25 7/28/2017 11:21:09 AM
  • Wedbush Is Raising NovoCure (NVCR) 2018 Rev. Estimate To 250.2 M From 240.9 M 7/28/2017 11:20:33 AM
  • Wedbush Is Increasing NovoCure (NVCR) 2017 Rev. Estimate To 162.8 M From 160.0 M 7/28/2017 11:20:15 AM
  • Wedbush Is Increasing NovoCure (NVCR) 4Q17 Rev. Estimate To 47.2 M From 46.7 M 7/28/2017 11:13:50 AM
  • Wedbush Is Increasing NovoCure (NVCR) 3Q17 Rev. Estimate To 42.2 M From 41.7 M 7/28/2017 11:13:29 AM
Copyright © 2026 RTTNews. All rights reserved. By using this site, you agree to the Terms of Service. About Us   |   Contact Us   |   Privacy   |   Sitemap